Benten Biotech
Loading
Go back to news
Events 4 days ago

Coming soon: Recombinant Antigen Panel for IBV Variants

{"ops":[{"insert":"Are Your IBV Vaccines Covering the Right Variants?"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nA standardized approach to evaluate antigenic coverage across IBV variants impacting global poultry production.\n\n"},{"attributes":{"bold":true},"insert":"IBV is not static."},{"insert":"\nYour evaluation framework shouldn’t be either.\n\n"},{"insert":"Explore how this applies to your work:\n\n"},{"attributes":{"link":"https://forms.gle/6L2tEUdFoUZvt2dv7","underline":true,"bold":true},"insert":"Request information"},{"insert":"\n\nWhy vaccination is not always enough"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nInfectious Bronchitis Virus (IBV) remains one of the most persistent challenges in poultry production.\nDespite routine vaccination, outbreaks and performance losses continue to occur.\n\nIn many cases, the problem is not vaccination — it is mismatch.\n\nMismatch between:\nvaccine strains"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"and circulating variants"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nA constantly evolving antigenic landscape"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nIBV is characterized by high variability, with multiple lineages co-circulating across regions:\n\nUS: Mass (GI-1), Ark (GI-9)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Europe: 793B / 4/91 (GI-13)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Asia / global spread: QX (GI-19)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Latin America: GI-11"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Middle East (Turkey, Egypt, Gulf): GI-23 (Variant 2)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nThese variants are no longer regional. They evolve, spread, and increasingly overlap.\n\nThe missing piece"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nToday, there is no standardized way to:\n\nCompare immune responses across IBV variants"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Evaluate antigenic coverage consistently"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Support data-driven vaccine strain selection"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nMost decisions are still made without a comparable framework.\n\nThe industry needs to move:\n"},{"attributes":{"bold":true},"insert":"From evaluating individual strains → to understanding antigenic coverage across variant systems"},{"insert":"\n\nStandardized IBV antigen panel"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nBenten Biotech is developing a standardized panel of recombinant IBV antigens representing major global lineages, including:\n\nGI-1 (Mass)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"GI-9 (Ark)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"GI-13 (793B)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"GI-19 (QX)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"GI-11 (Latin America)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"GI-23 (Middle East Variant 2)"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nWhat this enables:"},{"attributes":{"header":3},"insert":"\n"},{"insert":"\nVaccine strain selection"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Antigenic coverage assessment"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Diagnostic assay development"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nAll antigens are produced under standardized conditions, enabling direct comparability.\n\nWho this is for:"},{"attributes":{"header":3},"insert":"\n"},{"insert":"\nVaccine manufacturers"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Poultry health laboratories"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Integrated poultry producers"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\n"},{"attributes":{"bold":true},"insert":"In IBV, vaccine effectiveness depends on matching the right variant."},{"insert":"\n\nExplore how this applies to your work"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nTell us about your work and we’ll share how this platform can support your specific IBV challenges:\n\n"},{"attributes":{"link":"https://forms.gle/6L2tEUdFoUZvt2dv7","underline":true,"bold":true},"insert":"Request information"},{"insert":"\n"}]}